# NYC Health + Hospitals/Bellevue – FDA Inspection, Nov 2, 2011

Source: https://www.keypedia.com/records/fda_inspections/nyc-health-hospitalsbellevue/a8c11ad5-2876-469e-97d2-9c8d036d9645
Source feed: FDA_Inspections

> FDA inspection 751621 of NYC Health + Hospitals/Bellevue, November 02, 2011. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 606 and 640. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 751621
- Company Name: NYC Health + Hospitals/Bellevue
- Inspection Date: 2011-11-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1235880 - 2024-03-28
- FDA Inspection 1168713 - 2022-05-06
- [FDA Inspection 1022121 - 2017-08-16](https://www.keypedia.com/records/fda_inspections/nyc-health-hospitalsbellevue/e9ad1e18-50f8-4acd-af63-aa2e95689864)
- [FDA Inspection 940685 - 2015-09-08](https://www.keypedia.com/records/fda_inspections/nyc-health-hospitalsbellevue/f7b4a245-a765-48a4-bced-a3d656e90cad)
- FDA Inspection 807822 - 2012-11-20

Company: https://www.keypedia.com/companies/nyc-health-hospitalsbellevue/d5f2f9fd-ac30-4cf7-b28a-24e8c83e025f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
